Cargando…

Medical expenditure and its influencing factors of patients with hypertension in Shanxi Province, China: a study based on ‘System of Health Accounts 2011’ and multiple-layer perceptron neural network

OBJECTIVES: To study the medical expenditure and influencing factors of patients with hypertension in Shanxi Province, China. DESIGN: A cross-sectional study. SETTING: 1088 medical institutions, including general hospitals, traditional Chinese medicine hospitals, special hospitals, basic medical ins...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Guojie, Fang, Quan, Ji, Xinyu, OuYang, Jing, Zhu, Yalan, Wang, Leying, Wang, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8895933/
https://www.ncbi.nlm.nih.gov/pubmed/35241463
http://dx.doi.org/10.1136/bmjopen-2020-048396
_version_ 1784663037148397568
author Liu, Guojie
Fang, Quan
Ji, Xinyu
OuYang, Jing
Zhu, Yalan
Wang, Leying
Wang, Xin
author_facet Liu, Guojie
Fang, Quan
Ji, Xinyu
OuYang, Jing
Zhu, Yalan
Wang, Leying
Wang, Xin
author_sort Liu, Guojie
collection PubMed
description OBJECTIVES: To study the medical expenditure and influencing factors of patients with hypertension in Shanxi Province, China. DESIGN: A cross-sectional study. SETTING: 1088 medical institutions, including general hospitals, traditional Chinese medicine hospitals, special hospitals, basic medical institutions and public health institutions. PARTICIPANTS: 180 441 hypertensive outpatients and 14 763 inpatients from 1 January to 31 December 2017. PRIMARY AND SECONDARY OUTCOME MEASURES: Curative care expenditure for hypertension (CCE(ht)) was measured based on System of Health Accounts 2011. Influenced factors were analysed by univariate analysis and multiple layer perceptron neural network. RESULTS: In 2017, CCE(ht) was US$307.71 million, accounting for 3.63% of total CCE and 0.14% of gross domestic product (GDP) in Shanxi Province of China. CCE of hypertensive outpatients (CCE(ht-out)) and inpatients (CCE(ht-in)) accounted for 44.49% and 55.51% of CCE(ht). Drug fee accounted for 81.55% of CCE(ht-out) and 22.50% of CCE(ht-in), respectively. The top three influencing factors were drug fee, surgical fee and hospitalisation days for inpatients, and drug fee, examination fee and test fee for outpatients. CONCLUSIONS: The medical expenditure of hypertension is still heavy for individuals and society. The diagnosis and treatment capacities of primary healthcare system has been enhanced. New rural cooperation medical insurance and urban employee basic medical insurance have a trend of overusing, and the burden of family healthcare expenditure is still heavy. To ease the economic burden of patients with hypertension and improve the efficiency of social resources utilisation, policymakers should pay more attention to key groups, further increase support for primary healthcare system, standardise the treatment and reimbursement of hypertension and incline the reimbursement policy to outpatient service.
format Online
Article
Text
id pubmed-8895933
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-88959332022-03-22 Medical expenditure and its influencing factors of patients with hypertension in Shanxi Province, China: a study based on ‘System of Health Accounts 2011’ and multiple-layer perceptron neural network Liu, Guojie Fang, Quan Ji, Xinyu OuYang, Jing Zhu, Yalan Wang, Leying Wang, Xin BMJ Open Health Economics OBJECTIVES: To study the medical expenditure and influencing factors of patients with hypertension in Shanxi Province, China. DESIGN: A cross-sectional study. SETTING: 1088 medical institutions, including general hospitals, traditional Chinese medicine hospitals, special hospitals, basic medical institutions and public health institutions. PARTICIPANTS: 180 441 hypertensive outpatients and 14 763 inpatients from 1 January to 31 December 2017. PRIMARY AND SECONDARY OUTCOME MEASURES: Curative care expenditure for hypertension (CCE(ht)) was measured based on System of Health Accounts 2011. Influenced factors were analysed by univariate analysis and multiple layer perceptron neural network. RESULTS: In 2017, CCE(ht) was US$307.71 million, accounting for 3.63% of total CCE and 0.14% of gross domestic product (GDP) in Shanxi Province of China. CCE of hypertensive outpatients (CCE(ht-out)) and inpatients (CCE(ht-in)) accounted for 44.49% and 55.51% of CCE(ht). Drug fee accounted for 81.55% of CCE(ht-out) and 22.50% of CCE(ht-in), respectively. The top three influencing factors were drug fee, surgical fee and hospitalisation days for inpatients, and drug fee, examination fee and test fee for outpatients. CONCLUSIONS: The medical expenditure of hypertension is still heavy for individuals and society. The diagnosis and treatment capacities of primary healthcare system has been enhanced. New rural cooperation medical insurance and urban employee basic medical insurance have a trend of overusing, and the burden of family healthcare expenditure is still heavy. To ease the economic burden of patients with hypertension and improve the efficiency of social resources utilisation, policymakers should pay more attention to key groups, further increase support for primary healthcare system, standardise the treatment and reimbursement of hypertension and incline the reimbursement policy to outpatient service. BMJ Publishing Group 2022-03-03 /pmc/articles/PMC8895933/ /pubmed/35241463 http://dx.doi.org/10.1136/bmjopen-2020-048396 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Health Economics
Liu, Guojie
Fang, Quan
Ji, Xinyu
OuYang, Jing
Zhu, Yalan
Wang, Leying
Wang, Xin
Medical expenditure and its influencing factors of patients with hypertension in Shanxi Province, China: a study based on ‘System of Health Accounts 2011’ and multiple-layer perceptron neural network
title Medical expenditure and its influencing factors of patients with hypertension in Shanxi Province, China: a study based on ‘System of Health Accounts 2011’ and multiple-layer perceptron neural network
title_full Medical expenditure and its influencing factors of patients with hypertension in Shanxi Province, China: a study based on ‘System of Health Accounts 2011’ and multiple-layer perceptron neural network
title_fullStr Medical expenditure and its influencing factors of patients with hypertension in Shanxi Province, China: a study based on ‘System of Health Accounts 2011’ and multiple-layer perceptron neural network
title_full_unstemmed Medical expenditure and its influencing factors of patients with hypertension in Shanxi Province, China: a study based on ‘System of Health Accounts 2011’ and multiple-layer perceptron neural network
title_short Medical expenditure and its influencing factors of patients with hypertension in Shanxi Province, China: a study based on ‘System of Health Accounts 2011’ and multiple-layer perceptron neural network
title_sort medical expenditure and its influencing factors of patients with hypertension in shanxi province, china: a study based on ‘system of health accounts 2011’ and multiple-layer perceptron neural network
topic Health Economics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8895933/
https://www.ncbi.nlm.nih.gov/pubmed/35241463
http://dx.doi.org/10.1136/bmjopen-2020-048396
work_keys_str_mv AT liuguojie medicalexpenditureanditsinfluencingfactorsofpatientswithhypertensioninshanxiprovincechinaastudybasedonsystemofhealthaccounts2011andmultiplelayerperceptronneuralnetwork
AT fangquan medicalexpenditureanditsinfluencingfactorsofpatientswithhypertensioninshanxiprovincechinaastudybasedonsystemofhealthaccounts2011andmultiplelayerperceptronneuralnetwork
AT jixinyu medicalexpenditureanditsinfluencingfactorsofpatientswithhypertensioninshanxiprovincechinaastudybasedonsystemofhealthaccounts2011andmultiplelayerperceptronneuralnetwork
AT ouyangjing medicalexpenditureanditsinfluencingfactorsofpatientswithhypertensioninshanxiprovincechinaastudybasedonsystemofhealthaccounts2011andmultiplelayerperceptronneuralnetwork
AT zhuyalan medicalexpenditureanditsinfluencingfactorsofpatientswithhypertensioninshanxiprovincechinaastudybasedonsystemofhealthaccounts2011andmultiplelayerperceptronneuralnetwork
AT wangleying medicalexpenditureanditsinfluencingfactorsofpatientswithhypertensioninshanxiprovincechinaastudybasedonsystemofhealthaccounts2011andmultiplelayerperceptronneuralnetwork
AT wangxin medicalexpenditureanditsinfluencingfactorsofpatientswithhypertensioninshanxiprovincechinaastudybasedonsystemofhealthaccounts2011andmultiplelayerperceptronneuralnetwork